Related by context. All words. (Click for frequent words.) 71 hamartomas 70 carcinoid 70 medulloblastomas 68 somatic mutations 68 ALK mutations 67 miRNA expression 67 schwannomas 67 monozygotic twins 67 ependymoma 67 sarcomatoid 67 missense mutations 67 adenocarcinomas 67 aneuploid cells 67 osteosarcomas 66 supratentorial 66 neuroblastomas 66 histologic subtypes 66 mucinous 66 HbF 66 PTPN# 66 GISTs 66 molecular subtypes 66 seminomas 66 PARP inhibition 66 histological subtypes 66 sporadic ALS 66 meningiomas 66 serous ovarian cancer 66 epithelial tumors 66 mesotheliomas 65 microRNA expression 65 renal cell carcinomas 65 Gliomas 65 chromosomal aberrations 65 molecular abnormalities 65 oligodendrogliomas 65 neuropilin 65 malignant prostate 65 basal cell carcinoma BCC 65 inherited mutations 65 ADPKD 65 methylation patterns 65 demyelinating 65 de novo mutations 65 gastric carcinoma 65 DNA methylation patterns 65 chromosomal anomalies 64 pilocytic astrocytomas 64 genetic polymorphisms 64 myeloproliferative diseases 64 S. maltophilia 64 astrocytomas 64 aneuploidies 64 neuroblastoma tumors 64 pulmonary metastasis 64 teratoma 64 K ras mutations 64 neoplasm 64 monogenic 64 breast carcinomas 64 gene expression profiles 64 cisplatin resistant 64 pathogenic mechanisms 63 miR #a [001] 63 MAPK pathway 63 histologic subtype 63 epigenetically 63 genomic rearrangements 63 epithelioid 63 breast carcinoma 63 ZNF# 63 KRAS oncogene 63 CDH1 63 N Myc 63 chromosome rearrangements 63 beta1 integrin 63 lung adenocarcinomas 63 clinicopathologic 63 ovarian tumors 63 synovial cells 63 chromosomal rearrangement 63 dizygotic twins 63 T1DM 63 hepatocellular carcinomas 63 biochemical abnormalities 63 microdeletions 63 carcinoids 63 HER2 expression 63 immunocompetent 63 myopathies 63 paragangliomas 63 Papillary 63 clinicopathological 63 familial ALS 63 GBM tumors 63 IgG4 63 Clusterin 63 medulloblastoma 63 colorectal carcinoma 63 B7 H3 63 pituitary adenomas 63 BMPR2 63 MC1R gene 63 metastatic melanomas 63 hamartoma 63 germline mutations 63 lymphoma subtypes 63 genetic loci 63 demyelinating diseases 63 mtDNA mutations 63 haematopoietic 63 renal tumors 63 endometrioid 63 isotypes 63 microRNA molecules 63 genomic alterations 63 papillary RCC 63 pancreatic adenocarcinoma 63 motor neuron degeneration 63 cellular prion protein 63 immunostaining 63 peptide antigens 63 FLT3 63 sarcomas 63 alpha synuclein gene 62 TMPRSS2 ERG 62 malignant lesions 62 microRNA miR 62 epithelial tissues 62 transgene expression 62 GSTP1 62 leiomyoma 62 MLL gene 62 gene expression patterns 62 malignancies 62 premalignant lesions 62 hyperplastic 62 cnidarians 62 embryonal 62 alpha synuclein protein 62 protein isoforms 62 miRNA molecules 62 thyrotropin 62 antisense inhibition 62 Wwox 62 neoplasms 62 #p# [003] 62 epilepsies 62 chromosome aberrations 62 miRNA expression patterns 62 pathogenic mutations 62 Leydig cell 62 renal carcinoma 62 leiomyomas 62 pulmonary metastases 62 GPC5 62 Medullary thyroid cancer 62 GPx 62 thyroid carcinoma 62 demyelination 62 breast cancer subtypes 62 TLE3 62 lymphoid cells 62 neuroendocrine tumors 62 miRs 62 EoE 62 demyelinating disease 62 transgenic mouse models 62 Histologically 62 androgen receptor AR 62 HLA B# 62 uveal melanoma 62 PrPSc 62 mammary cancers 62 carcinoid tumors 62 murine models 62 CNVs 62 malignant pancreatic 62 DNA rearrangements 62 Glioma 62 ccRCC 62 #q#.# [001] 62 virulence genes 62 GRP# 62 neurite outgrowth 62 histopathologic examination 62 HLA genes 62 histologically 62 miR #a [002] 62 atherosclerotic lesions 62 metastatic lesions 62 trophoblast cells 62 tumor specific antigen 62 mRNA expression 62 pleomorphic 62 bronchial epithelial cells 62 LRP5 62 IgA deficiency 62 TCF#L# gene 62 histologies 62 BRAF gene 62 metaplasia 62 metabolomic profiles 62 PNET 62 PC# cells 62 OGG1 62 N. gonorrhoeae 62 Neural stem cells 62 breast endometrial 62 familial clustering 62 neurofibromas 62 hematologic disorders 62 MLL2 62 metastatic neuroendocrine tumors 62 sCJD 62 Nedd4 61 Sjögren syndrome 61 telomere dysfunction 61 EGFR gene 61 myeloproliferative 61 WT1 61 extramedullary 61 TTR gene 61 KRAS mutations 61 monozygotic 61 EGF receptors 61 HER2 receptor 61 myelofibrosis polycythemia vera 61 methylation markers 61 STAT4 61 ANCA associated 61 LRRK2 gene 61 white matter hyperintensities 61 tumor biopsies 61 liver metastasis 61 morphologic 61 ERBB2 61 anti angiogenic drugs 61 unmutated 61 nonmelanoma skin cancers 61 gastric cancers 61 SOD1 61 chromosome #q#.# [001] 61 histopathologic findings 61 p# mutations 61 HER2 overexpression 61 Squamous 61 Glioblastoma 61 MTHFR gene 61 immunohistochemical staining 61 melanoma tumors 61 neuroendocrine cancers 61 PCNSL 61 urothelial cancer 61 trophoblasts 61 bone marrow mesenchymal stem 61 carcinoid tumor 61 acinar cells 61 EGFR mutations 61 IKZF1 61 stress cardiomyopathy 61 familial pancreatic cancer 61 nonmetastatic 61 ORMDL3 61 gene rearrangements 61 CD# + [001] 61 chromatin structure 61 coding genes 61 NF1 61 neutralizing antibody responses 61 osteoblastic 61 MGUS 61 GIST tumors 61 leukaemias 61 genetic aberrations 61 tumoral 61 endocrine tumors 61 C1q 61 intraepithelial 61 biologic pathway 61 mesenchymal cells 61 lymphatic tissue 61 prostate cancer CaP 61 T#I [002] 61 immunized mice 61 FGFR2 61 Six3 61 sequence homology 61 NOD mice 61 pancreatic endocrine 61 metastatic tumors 61 tumor xenografts 61 mammary cells 61 Gleevec resistant 61 endogenous retroviruses 61 chromosomal rearrangements 61 cyclin E 61 endogenous ligands 61 paralogs 61 lymphomas 61 axillary lymph nodes 61 p# mutation 61 differential gene expression 61 biologies 61 BRAF V#E 61 susceptibility loci 61 infarcts 61 proto oncogene 61 #F FDG PET 61 activating mutations 61 neoplastic 61 Leukemias 61 neurofibroma 61 karyotypes 61 Smad3 61 soft tissue sarcomas 61 crystallin 61 KCNH2 61 lymphocytic 61 GBMs 61 viral genomes 61 penetrance 61 experimental autoimmune encephalomyelitis 61 phenotypic differences 61 vimentin 61 microcephalin 61 H#K#me# 61 Neuregulin 1 61 herpesviruses 61 IGFBP 3 61 NSCLC tumors 61 miRNA genes 61 heterozygotes 61 tRNA synthetases 61 lymphoid 61 pheochromocytoma 61 colorectal gastric 61 ataxias 61 congenital disorders 61 gliosis 61 microbiomes 61 TTR amyloidosis 61 cervical lymph nodes 61 colorectal polyp 60 xenograft tumors 60 BCL#A 60 mosaicism 60 synovial sarcoma 60 microarray experiments 60 luminal cells 60 piRNAs 60 prostate adenocarcinoma 60 cAMP signaling 60 circulating EPCs 60 embryonal rhabdomyosarcoma 60 malignant nodules 60 MDR1 60 invasive ductal 60 LRRK2 mutation 60 Legg Calvé Perthes disease 60 TGF beta signaling 60 transfusion syndrome 60 clusterin 60 mutated K ras 60 Confocal microscopy 60 urothelial carcinoma 60 gastrointestinal stromal tumors GISTs 60 CYP#C# gene 60 papillary 60 MYCN amplification 60 KIF6 gene 60 epigenetic changes 60 clade B 60 TCF#L# 60 myelomas 60 C#Y 60 biologic pathways 60 S#A# [002] 60 genetic heterogeneity 60 electrophysiologic 60 haematological 60 Fas ligand 60 Basal cell 60 glioblastoma tumors 60 tumor subtypes 60 PIK3CA 60 neurosensory 60 somatic mutation 60 FGFs 60 germline mutation 60 chromosome #p#.# 60 HLA DR 60 leukemias lymphomas 60 squamous 60 isotype 60 histone modifications 60 gastric cardia 60 mRNA transcripts 60 neuropathologic 60 neutralizing antibody 60 thyroglobulin 60 genomic variants 60 uPAR 60 breast pancreatic 60 endostatin 60 antibody titers 60 atypical hyperplasia 60 ductal lobular 60 clonally 60 RNA sequences 60 serum antibodies 60 lobular carcinomas 60 holoprosencephaly 60 SSc 60 neuronal stem cells 60 MGd 60 Htt 60 Cryptococcus neoformans 60 gastric adenocarcinoma 60 gene amplification 60 splice variants 60 oncoprotein 60 Colon polyps 60 cellularity 60 costimulatory 60 lymphoproliferative disorders 60 embryoid bodies 60 neurologic complications 60 neuroimaging studies 60 essential thrombocythemia 60 synuclein 60 nonhereditary 60 subcellular compartments 60 #p#.# [002] 60 underlying pathophysiology 60 Immunohistochemical analysis 60 euthymic patients 60 IDH1 mutation 60 Endometrial 60 micronuclei 60 ribosomal RNA rRNA 60 chronic myeloid 60 hematopoietic cells 60 kidney urologic 60 tenascin C 60 GNAQ 60 tumor suppressor protein 60 cardiac progenitor cells 60 genetic variants associated 60 genes CYP#C# 60 mononuclear cells 60 ductal breast cancer 60 neoplastic cells 60 syngeneic 60 CD# expression [001] 60 IL#B 60 E#F# 60 Hurthle cell 60 mutant allele 60 Estrogen Receptor 60 genetic syndromes 60 Endometrial cancer 60 resected pancreatic cancer 60 MAGE A3 60 tumorigenicity 60 MMP# 60 clefting 60 demyelinating disorders 60 transfected cells 60 PTEN mutations 60 non coding RNA 60 flavopiridol 60 papillomas 60 MSH2 60 #p#.# [001] 60 monozygotic twin 60 EGFRvIII 60 TMEM#B 60 epithelial cancers 60 prostate carcinoma 60 generalized epilepsy 60 troponin T 60 Upregulation 60 β1 60 IDH mutations 60 squamous cell lung cancer 60 immunoreactivity 60 esophageal squamous cell carcinoma 60 differentially expressed genes 60 immunohistochemical 60 TET2 60 metastatic prostate 60 oncologic outcomes 60 histopathologic 60 pDCs 60 fungal genomes 60 mTOR inhibitors 60 T2DM 60 IL 1ß 60 ovarian lung 60 epithelia 60 pathogenetic 60 Relapsing remitting MS 60 ductal adenocarcinoma 60 RRM1 60 thyroid carcinomas 60 p# biomarker 60 MC1R 60 Activating mutations 59 morphologically 59 melatonin receptor 59 nonsmall cell lung cancer 59 alveolar epithelial cells 59 CYP#B# 59 CTVT 59 breast lesions 59 glioma cells 59 genetic determinants 59 untreated celiac disease 59 papillary renal cell carcinoma 59 neural crest 59 systemic lupus erythematosus SLE 59 KRAS gene 59 mutant mouse 59 HER2 positive cancers 59 chromosomal translocations 59 Mesothelin 59 pancreatic lung 59 V#F mutation 59 ductal 59 JAK2 enzyme 59 colorectal carcinomas 59 brain lesions 59 lymphangiogenesis 59 CIN3 59 cutaneous lesions 59 lobular breast cancer 59 mesenteric 59 precursor lesions 59 malignant lymphomas 59 Sarcomas 59 mesothelin 59 CC genotype 59 transgenic mouse model 59 adenomatous 59 serotonin synthesis 59 CEACAM1 59 NPHP 59 glial tumors 59 ectoderm 59 transgenic rats 59 bilaterians 59 lesional 59 vertebrate embryos 59 choriocarcinoma 59 epithelial tissue 59 hepatic lesions 59 genetic alterations 59 homodimer 59 plexiform 59 lipomas 59 phenotypic variation 59 sonographic findings 59 TSLP 59 benign neoplasms 59 pancreatic islet 59 TOP2A 59 ERK signaling 59 cardiac fibroblasts 59 prognostic markers 59 distinct subtypes 59 radionuclide therapy 59 baseline LDH 59 somatostatin receptors 59 Brain metastases 59 polypoid 59 Epidermal Growth Factor Receptor 59 neuroendocrine 59 JAK mutations 59 juvenile idiopathic arthritis 59 Prox1 59 ADAMTS# 59 gene BRCA2 59 normal karyotype 59 Th2 cytokines 59 HGPIN 59 Carcinoid tumors 59 Meningiomas 59 prognostic significance 59 3'UTR 59 miR #b [002] 59 polycythemia vera PV 59 TRAIL induced apoptosis 59 histologic findings 59 Wnt signaling pathway 59 molecularly defined 59 PB1 F2 59 basal cells 59 epigenetic markers 59 CYT# potent vascular disrupting 59 NOD mouse 59 UCRs 59 interleukins 59 vestibular schwannomas 59 nasopharyngeal carcinoma 59 lobular carcinoma 59 CD1d 59 ABCB1 59 proteolytic cleavage 59 PCA3 gene 59 endocasts 59 Li Fraumeni 59 lung metastasis 59 SOD2 gene 59 globin genes 59 SMAD4 59 beta globin gene 59 Haptoglobin 59 ovarian carcinomas 59 proteins misfold 59 histologic 59 MC4R gene 59 autoinflammatory diseases 59 qRT PCR 59 ultrastructural 59 ovarian carcinoma 59 extracranial 59 mitochondrial dysfunction 59 FTLD 59 Glioblastomas 59 noncoding RNAs 59 vitamin D receptors 59 anemias 59 nonalcoholic steatohepatitis NASH 59 GH deficiency 59 distant metastasis 59 paraneoplastic 59 Cathepsin B 59 thyroid nodules 59 MLH1 59 liver metastases 59 IL #R 59 mutant proteins 59 MMP9 59 developmental abnormalities 59 colorectal adenocarcinoma 59 BRAF mutations 59 nAChRs 59 NF1 gene 59 EphA2 59 ERK2 59 MALT lymphoma 59 previously undescribed 59 cholangiocarcinoma 59 pathophysiological mechanisms 59 Medulloblastoma 59 histocompatibility 59 myeloproliferative neoplasms 59 transcriptional regulators 59 TAp# 59 neuroblastoma cells 59 Hutchinson Gilford progeria 59 neural crest stem cells 59 L. pneumophila 59 hematopoietic cancers 59 chimpanzee genomes 59 HHV 6 59 prostate carcinomas 59 #q#.# [002] 59 rs# [002] 59 primitive neuroectodermal tumors 59 JMML 59 circadian genes 59 cystic lesions 59 CagA 59 neoplasias 59 amyloid deposits 59 microvessels 59 FGFR3 59 xenograft models 59 CDK4 59 tonsillar 59 squamous cell carcinoma SCC 59 sphingolipid 59 TERT 59 HLA alleles 59 IL 7R 59 allogeneic HSCT 59 gene polymorphisms 59 cell carcinomas 59 FGFR4 59 nodal metastasis 59 skeletal metastases 59 immunoregulation 59 Hashimoto thyroiditis 59 incidentalomas 59 eosinophilic 59 TGFBR1 * 6A 59 messenger RNAs mRNAs 59 pathologic diagnosis 59 malignant brain 59 muscular dystrophies 59 System IPSS 59 mitochondrial metabolism 59 neural cells 59 neuroligins 59 degenerative neurological diseases 59 chromosomal translocation 59 oncogenic HPV types 59 Glucocorticoids 59 myogenic 59 congenital anomalies 59 Metastases 59 synovial 59 SPINK1 59 neoplastic lesions 59 EBV infection 59 malignant ovarian 59 multiprotein complex 59 PTEN protein 59 amyloid deposition 59 myeloma cells 59 phenotypic expression 59 P cadherin 59 C. neoformans 59 molecular signaling pathways 59 malignant fibrous histiocytoma 59 paraganglioma 59 L1 retrotransposons 59 medically inoperable 58 endometrial cancers 58 GBA mutations 58 histopathological 58 angiosarcoma 58 pre malignant lesions 58 PALB2 58 invasive carcinomas 58 chromosome #q# [001] 58 autistic regression 58 gastric carcinogenesis 58 lung carcinomas 58 epigenetic modification 58 ATG#L# 58 APOE e4 58 genome rearrangements 58 apoE4 58 nondemented 58 anaplastic 58 EZH2 58 malignant neoplasm 58 histological subtype 58 Cyclin D1 58 orthotopic model 58 Parkinsonian Syndromes 58 JAK2 58 idiopathic myelofibrosis 58 oxidized lipids 58 chromosomal alterations 58 Genetic variants 58 hypermethylation 58 antitumor efficacy 58 EGFR inhibitors 58 benign moles 58 basal cell nevus syndrome 58 circulating endothelial cells 58 p#INK#a 58 Wnts 58 Lymphoid 58 Li Fraumeni syndrome 58 spontaneous mutations 58 eIF 4E 58 cell adhesion molecule 58 kinase inhibition 58 dopamine receptor gene 58 troponins 58 oncoproteins 58 C EBP alpha 58 fraternal twin pairs 58 GSTM1 58 aneuploid 58 karyotype 58 Mesenchymal 58 etiologic 58 Immunohistochemistry 58 tNOX 58 taxane therapy 58 Lymphomas 58 BRCA2 mutation carriers 58 VHL gene 58 neurological manifestations 58 radiosensitive 58 #q# [001] 58 hypoperfusion 58 allodynia 58 PCa 58 beta amyloid peptides 58 immunodeficiencies 58 Symadex 58 retroviral vectors 58 DHFR 58 HGPS 58 hepatoma 58 adrenal cortex 58 bexarotene 58 mutated KRAS 58 breast cancer metastasis 58 orthologs 58 micro RNA 58 #S rRNA gene 58 HIV HCV coinfected 58 arterial calcification 58 mRNA molecules 58 commonly mutated genes 58 MT1 MMP 58 osteoid 58 myeloproliferative disorders 58 mitochondrial DNA mtDNA 58 protein fragment 58 MMP inhibitors 58 haematologic 58 androgen excess 58 HOTAIR 58 VIPR2 58 thymidylate synthase TS 58 Mutational 58 microdeletion 58 glycosylated 58 HAAH 58 apoE 58 airway hyperresponsiveness 58 miRNAs miR 58 anterior uveitis 58 KRAS variant 58 allelic variants 58 localized renal 58 mesothelial cells 58 tumor regressions 58 neuronal cells 58 Anthracycline 58 TIMP 1 58 CHD7 58 TP# mutation 58 Fibroblast 58 telomere lengths 58 inherited retinal degeneration 58 radiosensitivity 58 osteochondromas 58 antibody IgE 58 tumors 58 Glioblastoma multiforme 58 genomically 58 Malignant tumors 58 microRNAs miRNAs 58 tau aggregates 58 Dpp 58 CMV infection 58 VNTR 58 transthyretin amyloidosis 58 interferon γ 58 carcinomatosis 58 GRNCM1 58 Myelodysplastic syndromes MDS 58 Acute myeloid leukemia 58 thymoma 58 hindbrain 58 spongiform encephalopathies 58 K ras gene 58 isoenzymes 58 metastatic lymph nodes 58 Lafora disease 58 plasma kallikrein 58 IGFBP2 58 lymphoid tissue 58 HER2/neu 58 neuro degenerative disease 58 mice lacking 58 Sezary syndrome 58 serotonin receptor 58 dissociative disorders 58 bladder cancers 58 oncogenic mutations 58 mucins 58 mammary duct 58 pathophysiologic mechanism 58 FUS1 58 ABCB1 gene 58 colorectal cancer CRC 58 TRAIL R1 58 recessive mutation 58 DLC1 58 antiproliferative effects 58 abnormal cytology 58 VEGF inhibitors 58 Wilms tumor 58 thyroid cancers 58 gastric carcinomas 58 osteoclast 58 LIS1 58 protein tyrosine phosphatases 58 radiolabeled TM# 58 SNCA 58 BARD1 58 EGFR mutant 58 mastocytosis 58 HSF1 58 melanocyte 58 fibrotic disease 58 pathophysiologic 58 primary cilia 58 glioblastomas 58 CRISPR 58 granulosa cell 58 choroidal neovascularization 58 organogenesis 58 EGFR tyrosine kinase inhibitors 58 motor neuron diseases 58 NR#A# 58 HepG2 cells 58 IDH1 mutations 58 APOL1 58 advanced adenomas 58 transmembrane protein 58 innate immune responses 58 Foxp3 58 IgG1 antibodies 58 cortical dysplasia 58 unspecialized cells 58 Tumours 58 excitatory synapses 58 pancreatic tissue 58 HER2 gene 58 neuroblastoma tumor 58 colonic polyps 58 lymph node metastases 58 basal cell carcinomas 58 malignant lymphoma 58 node metastases 58 T1a 58 BRCA1 mutations 58 bronchogenic carcinoma 58 Rectal cancer 58 AGTR1 58 A. fumigatus 58 cultured neurons 58 #q# deletion 58 COX2 58 BRAF protein 58 mechanistic studies 58 viral proteins 58 ESBLs 58 Ras pathway 58 segmental duplications 58 calculi 58 microsatellite instability 58 molecularly targeted therapies 58 HIF 1alpha 58 eccrine 58 hypermethylated 58 tumor metastases 58 hypomethylation 58 Karlseder 58 lymphoid tumors 58 cathepsins 58 HER2 neu 58 TIMP 58 vitro experiments 58 insulin secreting beta 58 GRASPA ® 58 TACI mutations 58 Circulating tumor cells 58 acute myeloid 58 urolithiasis 58 Cholangiocarcinoma 58 chromophobe 58 autoimmune hemolytic anemia 58 Anaplastic 58 FGFR1 58 seminoma 58 genes BRCA1 58 unresectable tumors 58 esophageal carcinoma 58 phosphorylated tau 58 p#NTR 58 LRAT 58 mutant SOD1 58 Lymphocytes 58 indels 58 pathological hallmark 58 FUS protein 58 tumor antigen 58 p tau 58 epidermal cells 58 Acute myeloid leukemia AML 58 advanced adenoma 58 miRNAs 58 β amyloid 58 FOXP3 58 NKT cells 58 #p# [001]